SK

Sumeer Koul

Active Director Director DIN 02794821
DIN 02794821 First appointment Oct 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Oct 2009
Shareholding value •••• Premium profile

About Sumeer Koul

Data last updated:

Sumeer Koul is a Director at Bkrs Pharma Private Limited (since 2014), Director at Karbon Pharma Private Limited (since 2013) and Director at The Kashmiri Pandit Commerce Collective Foundation (since 2026). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹14.99 Cr; the largest is Bkrs Pharma Private Limited at ₹14.80 Cr (FY 2025). Earlier, Sumeer Koul was a Director at Pectro Biotech Private Limited (2018–2025) and Director at Alchemy Medicine Private Limited (2013–2014) and 2 more.

DIN 02794821
Primary Designation Director
Industry Pharma
First Appointment 12 Oct 2009
Oldest Company Age 14 yrs
Largest company Bkrs Pharma Private Limited · ₹14.80 Cr (FY 2025)
Combined revenue ₹14.99 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bkrs Pharma Private Limited U24230HR2012PTC045971
Director27 Mar 20142012₹14.80 Cr (FY 2025)Active
Karbon Pharma Private Limited U24210CH2013PTC034807
Director11 Nov 20132013₹19.8 Lakh (FY 2025)Active
Director25 Sep 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pectro Biotech Private Limited U51909HR2018PTC074490
Director11 Jun 20182018₹9.7 Lakh (FY 2025)Active
Alchemy Medicine Private Limited U24100DL2009PTC195559
Director28 Mar 20132009₹24.15 Cr (FY 2025)Active
Sai Tech Medicare Private Limited U24233HR2006PTC036501
Director12 Oct 20092006₹121 Cr (FY 2024)Active
Protech Bio Systems Private Limited U24239DL1998PTC096960
Director13 Oct 20111998₹48.99 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sumeer Koul

Directorship timeline

Open interactive timeline →
Karbon Pharma Private Limited
Bkrs Pharma Private Limited
The Kashmiri Pandit Commerce Collective Foundation
Pectro Biotech Private Limited
Premium access

Shareholding and investment profile for Sumeer Koul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumeer Koul

Sumeer Koul currently holds 3 directorships: Bkrs Pharma Private Limited (Director, since 27 Mar 2014, revenue ₹14.80 Cr (FY 2025)); Karbon Pharma Private Limited (Director, since 11 Nov 2013, revenue ₹19.8 Lakh (FY 2025)); The Kashmiri Pandit Commerce Collective Foundation (Director, since 25 Sep 2026).

Sumeer Koul was first appointed on 12 Oct 2009 as Director at Sai Tech Medicare Private Limited. The most recent appointment on record is 25 Sep 2026 at The Kashmiri Pandit Commerce Collective Foundation.

The 2 current companies of Sumeer Koul that report revenue have a combined latest revenue of ₹14.99 Cr: Bkrs Pharma Private Limited ₹14.80 Cr (FY 2025); Karbon Pharma Private Limited ₹19.8 Lakh (FY 2025).

Sumeer Koul held 4 earlier board appointments: Pectro Biotech Private Limited (Director, 11 Jun 2018 to 31 Dec 2025); Alchemy Medicine Private Limited (Director, 28 Mar 2013 to 31 Mar 2014); Sai Tech Medicare Private Limited (Director, 12 Oct 2009 to 29 Jun 2010); Protech Bio Systems Private Limited (Director, 13 Oct 2011 to 31 Mar 2014).

The current boards of Sumeer Koul's companies include Beenu Koul (Bkrs Pharma Private Limited), Neeraj Kaul (Karbon Pharma Private Limited), Rajesh Pandit (The Kashmiri Pandit Commerce Collective Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available